Researchers at the University of Illinois at Chicago have discovered a signaling mechanism in the bacterial ribosome that detects proteins that activate genes for antibiotic resistance. “The ribosome is one of the…
Post-pregnancy excess weight linked to high BMI before pregnancy, parenting stress and sedentary lifestyle
Post-pregnancy excess weight is likely caused by the impact of new parenthood stress on physical activity, Georgia Health Sciences University researchers say. In a study of 60 first-time mothers, researchers linked higher…
Antiepileptic drugs could make HIV drugs less effective
A Michigan State University researcher is looking to uncover the risks of treating seizures in HIV-positive patients, providing much-needed data on possible interactions between antiepileptic drugs and antiretroviral medicines that potentially could…
Nanoparticle therapy may improve survival after life-threatening blood loss
In an advance that could improve battlefield and trauma care, scientists at Albert Einstein College of Medicine of Yeshiva University have used tiny particles called nanoparticles to improve survival after life-threatening blood…
Portion of brain responsible for reading doesn’t require vision at all
The portion of the brain responsible for visual reading doesn’t require vision at all, according to a new study by researchers from the Hebrew University of Jerusalem and France. Brain imaging studies…
ETH scientists warn about impact of cell phone radiation in brain of healthy adults
Expert scientists working with Environmental Health Trust (EHT), a nonprofit research and educational group, say that new studies showing that cell phone radiation excites the brain strengthen the need for a major…
Knocking out genes completely and exclusively in Natural Killer cells
Our immune systems contain three fundamentally different types of cell: B-cells, T-cells and the mysteriously named Natural Killer cells (NK cells), which are known to be involved in killing tumour cells and…
Cerasome filled molecular-sized bubbles to target liver cancer cells
Nanotechnology may open a new door on the treatment of liver cancer, according to a team of Penn State College of Medicine researchers. They used molecular-sized bubbles filled with chemotherapy drugs to…
Dual lab tests accurately predict vein graft blood clots in patients during CABG
A team of heart experts at Johns Hopkins has found that dual lab tests of blood clotting factors accurately predict the patients whose blood vessels, in particular veins implanted to restore blood…
MWV announces availability of preservative pharmaceutical spray pumps for sampling
MeadWestvaco Corp. (NYSE:MWV) announced today the availability of its Preservative Free Pump Topical (PFP T) for sampling. This product, specifically engineered for topical applications, is the most recent innovation in its portfolio…
Cannabis ingredient can improve appetites and sense of taste in cancer patients
The active ingredient in cannabis can improve the appetites and sense of taste in cancer patients, according to a new study published online in the cancer journal, Annals of Oncology today. Loss…
Al Wasl Hospital gets “Baby-Friendly Hospital” status
DUBAI — In the presence of Her Royal Highness Princess Haya Bint Al Hussein, wife of His Highness Shaikh Mohammed Bin Rashid Al Maktoum, Vice-President and Prime Minister of the UAE and…
Scientists receive HHS grant to investigate DSC127 in treatment of skin injuries linked with radiation exposure
Derma Sciences, Inc. (Nasdaq: DSCI), a medical device and pharmaceutical company focused on advanced wound care, today announced that researchers who invented DSC127 have been awarded a $4.5 million, 16-month grant by…
ISCTM 7th annual meeting to discuss drug development based on amyloid hypothesis of Alzheimer’s disease
Continuing in their mission to promote advances in the development and use of CNS therapeutic agents, the International Society for CNS Clinical Trials and Methodology (ISCTM) met February 21, 2011 in Washington,…
Norgine, Tranzyme commences dosing in ulimorelin Phase 3 study for restoring GI function after surgery
Tranzyme Pharma and Norgine B.V., have initiated dosing of ulimorelin in the first of two, Phase 3 pivotal studies – ULISES (ULImorelin Safety and Efficacy Study). Ulimorelin is Tranzyme’s intravenous promotility agent…